Onkologie, Hämatologie - Daten und Informationen
SitemapSitemap  


6.5 Substitution von Immunglobulinen: Literatur

Autor/en: M. Hensel
Letzte Änderung: 15.05.2012
  • Anaissie EJ, Kontoyannis D, O'Brien S.
    Infections in patients with chronic lymphocytic leukemia treated with Fludarabine.
    Ann Intern Med 1998;129:559-566. PMID:9758577
    [Medline]


  • Apostopoulos A, Simeonidis A, Zoumbos N.
    Prognostic significance of immune function parameters in patients with chronic lymphocytic leukemia.
    Eur J Haematol 1990;44:39-44. PMID:2137786
    [Medline]


  • Besa EC.
    Use of intravenous immunoglobulin in chronic lymphocytic leukemia.
    Am J Med 1984;76:209-218. PMID:6424454
    [Medline]


  • Boughton BJ, Jackson N, Lim S, Smith N.
    Randomized trial of intravenous immunglobulin prophylaxis for patients with chronic lymphocytic leukaemia and secondary hypogammaglobulinaemia.
    Clin Lab Haetmatol 1995;17:75-80. PMID:7621634
    [Medline]


  • Chapel HM, Dicato M, Gamm H.
    Immunoglobulin replacement in patients with chronic lymphocytic leukaemia: a comparison of two dose regimens.
    Br J Haematol 1994a;88:209-212. PMID:7803248
    [Medline]


  • Chapel HM, Lee M, Hargreaves R, Pamphilon DH, Prentice AG.
    Randomised trial of intravenous immunoglobulin as prophylaxis against infection in plateau-phase multiple myeloma. The UK Group for Immunoglobulin Replacement Therapy in Multiple Myeloma.
    Lancet 1994b;343:1059-1063. PMID:7909099
    [Medline]


  • Chapel HM, Spickett GP, Ericson D, Engl W, Eibl MM, Bjorkander J.
    The Comparison of the Efficacy and Safety of Intravenous versus Subcutaneous Immunoglobulin Replacement Therapy.
    J Clin Immunol 2000;20:94-100. PMID:10821460
    [Medline]


  • Cooperative Group for the Study of Immunoglobulin in Chronic Lymphocytic Leukemia.
    Intravenous immunoglobulin for the prevention of infection in chronic lymphocytic leukemia. A randomized, controlled clinical trial.
    N Engl J Med 1988;319:902-907. PMID:2901668
    [Medline]


  • Dighiero G.
    Hypogammaglobulinemia and disordered immunity in CLL.
    In: Cheson BD (ed). Chronic lymphocytic leukemia.
    Scientific advances and clinical developments.Dekker, New York 1993, p.147-166.


  • Duhem C, Dicato MA, Ries F.
    Side-effects of intravenous immune globulins.
    Clin Exp Immunol 1994;97:79-83. PM:8033440
    [Medline]


  • Fahey JL, Scoggins R, Utz JP, Szwed CF.
    Infection, antibody response and gamma globulin components in multiple myeloma and macroglobulinemia.
    Am J Med 1963;35:698-707. PMID:14076022
    [Medline]


  • Foerster J.
    Chronic lymphocytic leukemia.
    In: Lee GR, Bithell TC, Foerster J, Athens JW, Lukens JN (eds).
    Wintrobe's clinical hematology.Lea & Febiger, Philadelphia, 1993, p. 2034-2053.


  • Gardulf A, Andersen V, Björkander J, Ericson D, Frøland SS, Gustafson R, Hammarström L, Jacobsen MB, Jonsson E, Möller G, et al.
    Subcutaneous Immunglobulin Replacement in Patients with Primary Antibody Deficiencies. Safety and Costs.
    The Lancet 1995;345:365-369. PMID:7845120
    [Medline]


  • Gardulf A, Hammarstrom L, Smith CI.
    Home treatment of hypogammaglobulinaemia with subcutaneous gammaglobulin by rapid infusion.
    Lancet 1991;338:162-166. PMID:1712881
    [Medline]


  • Glasmacher A, Schmidt-Wolf I.
    Stellenwert der Infektionsprophylaxe mit intravenösen Immunglobulinen in der Hämato-Onkologie.
    In: Kiehl MG, Naß WP, Volk HD (Hrsg).
    Immunmodulation mit Immunglobulinen bei Autoimmunerkrankungen und Infektionen.Thieme, Stuttgart, 2000, S. 137-142.


  • Griffiths H, Brennan V, Lea J, Bunch C, Lee M, Chapel H.
    Crossover study of immunoglobulin replacement therapy in patients with low-grade B-cell tumors.
    Blood 1989;73:366-368. PM:2492832
    [Medline]


  • Hargreaves RM, Lea JR, Griffiths H, Faux JA, Holt JM, Reid C, Bunch C, Lee M, Chapel HM.
    Immunological factors and risk of infection in plateau phase myeloma.
    J Clin Pathol 1995;48:260-266. PMID:7730490
    [Medline]


  • Hensel M, Kornacker M, Yammeni S, Egerer G, Ho AD.
    Disease activity and pretreatment, rather than hypogammaglobulinaemia, are major risk factors for infectious complications in patients with chronic lymphocytic leukaemia.
    Br J Haematol 2003;122:600-606. PMID:12899715
    [Medline]


  • Högy B, Keinecke H-O, Borte M.
    Pharmacoeconomic evaluation of immunoglobulin treatment in patients with antibody deficiencies from the perspective of the German statutory health insurance.
    Eur J Health Econ. 2005;6:24-9. PMID:15480920
    [Medline]


  • Itälä M, Helenius H, Nikoskelaien J.
    Infections and serum IgG levels in patients with chronic lymphocytic leukemia.
    Eur J Haematol 1992;48:266-270. PMID:1644158
    [Medline]


  • Jurlander J, Geisler CH, Hansen MM.
    Treatment of hypogammaglobulinaemia in chronic lymphocytic leukaemia by low-dose intravenous gammaglobulin.
    Eur J Haematol 1994;53:114-118. PMID:8088382
    [Medline]


  • Kay NE, Perri RT.
    Evidence that large granular lymphocytes from B-CLL patients with hypogammaglobulinemia down-regulate B-cell immunoglobulin synthesis.
    Blood 1989;73:1016-1019. PMID:2784065
    [Medline]


  • Kirch W, Gold R, Hensel M, Fasshauer M, Pittrow D, Huscher D, Reiser M, Stangel M, Baumann U, Borte M.
    Assessment of immunoglobulins in a long-term non-interventional study (SIGNS Study). Rationale, design, and methods.
    Med Klin (Munich). 2010;105:647-51. PMID:20878302
    [Medline]


  • Kirch W, Stangel M, Pittrow D, Baumann U, Fasshauer M, Huscher D et al. Immunoglobulins for primary or secondary immunodeficiency or for immunomodulation in neurological autoimmune diseases: insights from the prospective SIGNS registry.
    J Public Health 2012 (im Druck)


  • LAUER-Taxe [Online], Stand: Feb. 2011
    LAUER-FISCHER GmbH, Fürth (Hrsg.)
    URL:http://www2.lauer-fischer.de/produkte/arzneimitteldaten-online/webapor-lauer-taxe/
    [Online]


  • Molica S.
    Infections in chronic lymphocytic leukemia: risk factors and impact on survival and treatment.
    Leuk Lymphoma 1994;13:203-214. PMID:8049645
    [Medline]


  • Morrison VA.
    Infectious complications of chronic lymphocytic leukaemia: pathogenesis, spectrum of infection, preventive approaches.
    Best Pract Res Clin Haematol. 2010;23:145-53. PMID:20620978
    [Medline]


  • Morrison VA.
    The infectious complications of chronic lymphocytic leukemia.
    Semin Oncol 1998;25:98-106. PMID:9482531
    [Medline]


  • Poelsler G, Berting A, Kindermann J, Spruth M, Hämmerle T, Teschner W, Schwarz HP, Kreil TR.
    A new liquid intravenous immunoglobulin with three dedicated virus reduction steps: virus and prion reduction capacity.
    Vox Sanguinis 2008;94:184-192. PMID:18167162
    [Medline]


  • Raanani P, Gafter-Gvili A, Paul M, Ben-Bassat I, Leibovici L, Shpilberg O.
    Immunoglobulin prophylaxis in hematological malignancies and hematopoietic stem cell transplantation.
    Cochrane Database Syst Rev. 2008 Oct 8;(4):CD006501. PMID:18843719
    [Medline]


  • Raanani P, Gafter-Gvili A, Paul M, Ben-Bassat I, Leibovici L, Shpilberg O. Immunoglobulin prophylaxis in chronic lymphocytic leukemia and multiple myeloma: systematic review and meta-analysis.
    Leuk Lymphoma 2009;50:764-772. PMID:19330654
    [Medline]


  • Rozman C, Montserrat E, Vinolas N.
    Serum immunoglobulins in B-chronic lymphocytic leukemia. Natural history and prognostic significance.
    Cancer 1988;61:279-283. PMID:2446736
    [Medline]


  • Schmidt RE, Baumann U.
    Primäre und sekundäre Immundefekte. 2. Auflage.
    UNI-MED, Bremen, 2009, S. 75


  • Thomas MJ, Brennan VM, Chapel HH.
    Rapid subcutaneous immunoglobulin infusions in children.
    Lancet 1993;342:1432-1433. PMID:7694025
    [Medline]


  • Twomey JJ.
    Infections complicating multiple myeloma and chronic lymphocytic leukemia.
    Arch Intern Med 1973;132:562-565. PMID:4542660
    [Medline]


  • Weeks JC, Tierney MR, Weinstein MC.
    Cost effectiveness of prophylactic intravenous immune globulin in chronic lymphocytic leukemia.
    N Engl J Med 1991;325:81-86. PMID:1904989
    [Medline]


  • Young JA.
    Epidemiology and management of infectious complications of contemporary management of chronic leukemias.
    Infect Disord Drug Targets 2011;11:3-10. Review. PMID:21303335
    [Medline]



Arbeitsgemeinschaft Supportive Maßnahmen in der Onkologie, Rehabilitation u. Sozialmedizin d. Deutschen Krebsgesellschaft e.V. [Mehr]
Nach wie vor online verfügbar: die noch nicht aktualisierten Kapitel des Buches "Supportiv- therapie bei malignen Erkrank- ungen", bei ONKODIN publiziert in Kooperation mit "Deutscher Ärzte-Verlag", 2006. [Mehr]
Aktuelle Berichte vom 58th
ASH Annual Meeting 2016,
San Diego, Kalifornien, USA [Mehr]
2016 ASCO Annual Meeting - aktuelle Berichte. Dieser Service wird gefördert durch:
mehr 
[Mehr]